CadheRx

CadheRx is the developer of therapeutic antibodies designed to target and cure solid tumors. The company's antibodies are used to treat solid tumors that are resistant to other therapies, particularly epithelial cancers that are resistant to cetuximab and Herceptin, allowing patients to remove solid tumors without surgery.